MedTrace Logo

Treatment of Patients With Skin Burns Using Keratinocytes and Skin Fibroblasts

NCT04485962 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-07-24

No results posted yet for this study

Summary

Treatment of patients with burns of the skin of the 2nd degree using: autologous keratinocytes and skin fibroblasts mixed with collagen gel 7% (tissue equivalent of the skin)

Conditions

  • Burns

Interventions

BIOLOGICAL

Fibroblasts and keratinocytes

Autologous cultured fibroblasts and keratinocytes For PR: The name " fibroblasts and keratinocytes" is exactly the name of the cell product registered by our ministry of health. There is no trade or international name.

Sponsors & Collaborators

  • Belarusian Medical Academy of Post-Graduate Education

    collaborator OTHER

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Igor Volotovski, Prof · Head of the Lab of Institute of Biophysics and Cell Engineering

  • Vladimir Podgaiskiy, Prof · Head of the plastic surgery and combustiology

  • Alexey Chasnoit, Dr · Dean of the plastic surgery and combustiology

  • Zinaida Kvacheva, Dr · Lead Researcher of Institute of Biophysics and Cell Engineering

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04485962 on ClinicalTrials.gov